Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Junsik Park
Institutions:
Soonchunhyang University,
Soonchunhyang University Hospital Bucheon
Observed institutions:
Yonsei University,
Soonchunhyang University,
Korea Transport Institute,
Soonchunhyang University Hospital Bucheon
ORCID:
0000-0002-9928-4896
Observed ORCID:
0000-0002-9928-4896
OpenAlex ID:
A5017387486
Risk of COVID-19 Infection in Public Transportation: The Development of a Model
2021
·
Junsik Park
, Gurjoong Kim
·
International Journal of Environmental Research and Public Health
·
44
PDF
Provision of metropolitan demand responsive transit and attitude’s role in mode choice
2025
·
Junsik Park
, Sungtaek Choi
, et al.
·
Transportation Research Part D Transport and Environment
·
12
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trial
2026
·
Natalie Y L Ngoi
, Jung-Yun Lee
, et al.
·
The Lancet Oncology
·
10
Histology-specific ADC target landscapes in ovarian cancer and therapy-associated antigen downshift after ADC exposure
2026
·
Yong Jae Lee
, Junsik Park
, et al.
·
Gynecologic Oncology
·
4
The HER2 paradox in ovarian clear cell carcinoma: Expression and intrinsic resistance to trastuzumab deruxtecan (T-DXd).
2026
·
Junsik Park
, Soyeon Kim
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Comprehensive profiling of antibody-drug conjugate target expression in epithelial ovarian cancer with pre- and post-ADC longitudinal assessment.
2026
·
Yong jae Lee
, Eun Kyung Kim
, et al.
·
Journal of Clinical Oncology
·
2
Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer
2025
·
Jung Chul Kim
, Jung-Yun Lee
, et al.
·
Cancer Research and Treatment
·
2
Social Efficiency of Public Transportation Policy in Response to COVID-19: Model Development and Application to Intercity Buses in Seoul Metropolitan Area
2022
·
Junsik Park
, Gurjoong Kim
·
International Journal of Environmental Research and Public Health
·
2
PDF
Progression-free survival outcomes of first-line maintenance therapy in ovarian cancer stratified by BRCA and homologous recombination status: A multi-center real-world analysis.
2026
·
Young Joo Lee
, Se Ik Kim
, et al.
·
Journal of Clinical Oncology
Abstract 7445: Effector regulatory T-cell infiltration, ARID1A status, and Ex Vivo anti-PD-1 response in ovarian clear cell carcinoma: Insights from a comparative high-grade serous ovarian cancer cohort
2026
·
Junsik Park
, Eun Kyung Kim
, et al.
·
Cancer Research
Show more works
View as search
Works count:
10
Citation count:
78
H-index:
4
I10-index:
3
Year
Topic
Type